Inorganic Chemistry
Article
into a concentrated THF solution resulted in product as red crystals
suitable for X-ray diffraction (115 mg, 77.8%). H NMR (400 MHz,
CDCl3): δ 7.56 (t, 2H, Ar-H), 7.54 (t, 2H, Ar-H), 7.38 (t, 4H, Ar-H),
7.32−6.89 (m, 31H, Ar-H), 6.26 (m, 4H, Ar-H), 3.76 (br, 2H, CH2),
2.67 (br, 2H, CH2). 31P NMR (161.8 MHz, CDCl3): δ 198.8 (ddt, 1P,
(PPP)Pt−Cl (8). Ligand precusor [PPP]-Cl (97.0 mg, 0.150 mmol)
was dissolved in 10 mL of toluene and to this stirring light yellow
solution was added Pt(PPh3)4 (187 mg, 0.150 mmol). The reaction
mixture became deep red immediately. After stirring for 10 min, the
resulting red solution was filtered and concentrated in vacuo to about
5 mL. The concentrated toluene solution was stored in the freezer for
12 h (−35 °C), affording 8 as yellow crystals which were collected,
washed with toluene, and further dried in vacuo (98.0 mg, 77.6%). 1H
NMR (400 MHz, CD2Cl2): δ 7.68 (m, 4H, Ar-H), 7.47 (m, 10H, Ar-
H), 7.37 (m, 8H, Ar-H), 7.05 (d, 2H, Ar-H), 6.86 (q, 2H, Ar-H), 6.74
(t, 2H, Ar-H), 3.76(m, 2H, CH2), 3.38 (m, 2H, CH2). 31P NMR
1
2
2
1JPt−P = 445 Hz, JP−P(trans) = 52.1 Hz, JP−P(cis) = 9.2 Hz), 29.1 (ddt,
1
2
2
1P, JPt−P = 2443 Hz, JP−P(trans) = 52.1 Hz, JP−P(cis) = 22.0 Hz), 13.6
1
2
2
(ddd, 2P, JPt−P = 3446 Hz, JP−P(NHP) = 9.2 Hz, JP‑(PPh3) = 22.0 Hz),
−143.9 (sept, 1P, 1JP−F = 710 Hz). 13C NMR (100.5 MHz, CDCl3): δ
146.7, 134.6, 134.5, 134.1, 134.0, 132.7, 132.3, 132.1, 131.5, 131.3,
128.9, 128.8, 121.8, 119.2, 48.2. Anal. Calcd for C56H47N2F6P5Pt: C,
55.60; H, 3.91; N, 2.31. Found: C, 55.45; H, 4.01; N, 2.26.
1
1
(161.8 MHz, CD2Cl2): δ 224.8 (dt, JPt−P = 663 Hz, JP−P = 6.1 Hz),
1
1
12.1 (dd, JPt−P = 3304 Hz, JP−P = 6.1 Hz). 13C NMR (100.5 MHz,
CD2Cl2): δ 135.9, 134.8, 134.2, 132.2, 130.8 130.7, 128.3, 128.2, 119.2,
118.6, 48.6. Anal. Calcd for C38H32N2ClP3Pt: C, 54.33; H, 3.84; N,
3.33. Found: C, 54.28; H, 3.91; N, 3.16.
[(PPP)Pt(PMe3)][PF6] (4). Compound 3 (31.8 mg, 0.0262 mmol)
was dissolved in 10 mL of dichloromethane and to this red solution
was added trimethylphosphine (5.4 μL, 0.052 mmol). The reaction
mixture was allowed to stir further to ensure complete reaction. After 1
h, removal of all volatiles from the resulting yellow solution yielded
analytically pure product as yellow solid (25.7 mg, 95.6%). Crystals
suitable for X-ray crystallography were grown via vapor diffusion of n-
(PPP)Pt−Br (9). An identical procedure to that of compound 8 was
followed, using [PPP]-Br (84.5 mg, 0.123 mmol) and Pt(PPh3)4
1
(152.5 mg, 0.123 mmol) to yield 9 (76.5 mg, 70.6%). H NMR (400
MHz, CD2Cl2): δ 7.67 (m, 4H, Ar-H), 7.46−7.34 (m, 18H, Ar-H),
7.06 (m, 2H, Ar-H), 6.85 (q, 2H, Ar-H), 6.74 (t, 2H, Ar-H), 3.77(m,
2H, CH2), 3.34 (m, 2H, CH2). 31P NMR (161.8 MHz, CD2Cl2): δ
222.0 (dt, 1JPt−P = 607 Hz, 1JP−P = 6.1 Hz), 11.2 (dd, 1JPt−P = 3337 Hz,
1JP−P = 6.1 Hz). 13C NMR (100.5 MHz, CD2Cl2): 136.1, 134.8, 134.3,
132.1, 130.8 130.7, 128.4, 128.2, 119.4, 119.0, 48.8. Anal. Calcd for
C38H32N2BrP3Pt: C, 51.60; H, 3.65; N, 3.17. Found: C, 51.43; H, 3.72;
N, 3.08.
1
pentane into a concentrated dichloromethane solution of 4. H NMR
(400 MHz, CDCl3): δ 7.47 (m, 12H, Ar-H), 7.27 (m, 8H, Ar-H), 7.16
(m, 2H, Ar-H), 6.96 (m, 4H, Ar-H), 6.82 (t, 2H, Ar-H), 3.58 (m, 2H,
CH2), 3.18 (m, 2H, CH2), 0.65 (d, 9H, CH3). 31P NMR (161.8 MHz,
1
2
CDCl3): δ 205.5 (ddt, 1P, JPt−P = 496 Hz, JP−P(trans) = 54.9 Hz,
2JP−P(cis) = 9.1 Hz), 11.1 (ddd, 2P, JPt−P = 3149 Hz, JP−P(NHP) = 9.1
1
2
Hz, 2JP‑PMe3 = 26.5 Hz), −18.7 (ddt, 1P, 1JPt−P = 2221 Hz, 2JP−P(NHP)
=
2
1
54.9 Hz, JP‑(cis) = 26.5 Hz), −143.9 (sept, 1P, JP−F = 710 Hz). 13C
NMR (100.5 MHz, CDCl3): δ 134.7, 134.6, 134.4, 132.3, 132.0, 131.8,
129.7, 129.6, 121.5, 121.1, 49.5, 20.8. Anal. Calcd for C41H41N2F6P5Pt:
C, 48.01; H, 4.03; N, 2.73. Found: C, 47.83; H, 4.02; N, 2.63.
(PPP)Pd−Cl (5). Ligand precursor [PPP]-Cl (128 mg, 0.198
mmol) was dissolved in 10 mL of benzene; to this stirring pale yellow
solution was added Pd(PPh3)4 (229 mg, 0.198 mmol). The reaction
mixture became dark red immediately, and after 5 min, the dark red
solution was filtered and concentrated to about 2 mL. Upon standing
for 12 h at rt, yellow crystals formed and were washed with benzene
and further dried in vacuo to yield pure product (79.7 mg, 49.4%). 1H
NMR (400 MHz, CD2Cl2): δ 7.68 (m, 4H, Ar-H), 7.52 (m, 4H, Ar-
H), 7.48−7.41 (m, 10H, Ar-H), 7.36 (m, 4H, Ar-H), 7.19 (m, 2H, Ar-
(PPP)Pt−I (10). An identical procedure to that of compound 8 was
followed, using [PPP]-I (123.4 mg, 0.168 mmol) and Pt(PPh3)4
1
(208.5 mg, 0.168 mmol) to yield 10 (72.5 mg, 46.4%). H NMR
(400 MHz, CD2Cl2): δ 7.65 (m, 4H, Ar-H), 7.45−7.35 (m, 18H, Ar-
H), 7.07 (m, 2H, Ar-H), 6.90 (m, 2H, Ar-H), 6.75 (t, 2H, Ar-H), 3.79
(m, 2H, CH2), 3.29 (m, 2H, CH2). 31P NMR (161.8 MHz, CD2Cl2): δ
219.5 (dt, 1JPt−P = 486 Hz, 1JP−P = 6.4 Hz), 9.4 (dd, 1JPt−P = 3350 Hz,
1JP−P = 6.4 Hz). 13C NMR (100.5 MHz, CD2Cl2): δ 136.3, 134.9,
134.4, 132.0, 130.6, 130.7, 128.4, 128.1, 119.5, 119.2, 48.9. Anal. Calcd
for C38H32N2IP3Pt: C, 48.99; H, ; 3.46N, 3.01. Found: C, 48.83; H,
3.51; N, 2.94.
[(PPP)Pt]2[PF6]2 (11). Compound 8 (47.4 mg, 0.0564 mmol) was
dissolved in 10 mL of THF and to this yellow solution was added
TlPF6 (19.7 mg, 0.0564 mmol). The mixture was allowed to stir at rt
for 12 h to ensure complete reaction, and the resulting red solution
was filtered through a pad of Celite to remove TlCl. Removal of the
volatiles from the filtrate in vacuo afforded the crude product as a dark
solid. Crystallization of the crude product via vapor diffusion of diethyl
ether into a concentrated THF solution yielded product as dark red
crystals suitable for X-ray diffraction. 1H NMR (400 MHz, CD2Cl2): δ
7.58 (m, 6H, Ar-H), 7.49 (m, 2H, Ar-H), 7.31 (m, 10H, Ar-H), 7.07
(m, 4H, Ar-H), 6.99 (t, 2H, Ar-H), 6.80 (br, 2H, Ar-H), 6.61 (br, 2H,
Ar-H), 3.43 (m, 2H, CH2), 3.06 (m, 2H, CH2). 31P NMR (161.8 MHz,
CD2Cl2): δ 257.5 (dd, 1JPt−P = 2161 Hz, 2JP−P = 42 Hz), 5.4 (br, 2JP−P
H), 6.97 (m, 2H, Ar-H), 6.88 (t, 2H, Ar-H), 3.83 (m, 2H, CH2), 3.36
1
(m, 2H, CH2). 31P NMR (161.8 MHz, CD2Cl2): δ 248.6 (t, JP−P
=
28.3 Hz), 6.2 (d, 1JP−P = 28.3 Hz). 13C NMR (100.5 MHz, CD2Cl2): δ
136.1, 134.8, 134.3, 131.8, 130.5, 130.4, 128.5, 128.4, 121.7, 121.2,
51.6.Anal. Calcd for C38H32N2ClP3Pd: C, 60.74; H, 4.29; N, 3.73.
Found: C, 60.58; H, 4.37; N, 3.59.
(PPP)Pd−Br (6). An identical procedure to that of compound 5
was followed, using [PPP]-Br (53.7 mg, 0.078 mmol) and Pd(PPh3)4
1
(90.0 mg, 0.078 mmol) to yield 6 (40.0 mg, 64.5%). H NMR (400
MHz, CD2Cl2): δ 7.68 (m, 4H, Ar-H), 7.53 (m, 4H, Ar-H), 7.51−7.43
(m, 10H, Ar-H), 7.37 (m, 4H, Ar-H), 7.21 (m, 2H, Ar-H), 6.98 (m,
2H, Ar-H), 6.89 (t, 2H, Ar-H), 3.84(m, 2H, CH2), 3.36 (m, 2H, CH2).
31P NMR (161.8 MHz, CD2Cl2): δ 246.1 (t, 1JP−P = 25.2 Hz), 6.0 (d,
1JP−P = 25.2 Hz). 13C NMR (100.5 MHz, CD2Cl2): δ 136.3, 134.7,
134.4, 131.8, 130.5, 130.4, 128.4, 128.3, 121.9, 121.4, 51.9. Repeated
attempts to obtain satisfactory combustion analysis data for 6 were
unsuccesful as a result of an unidentified minor impurity that
cocrystallized with 6.
1
= 42 Hz), −143.9 (sept, JP−F = 710 Hz). Attempts to obtain
satisfactory 13C NMR and combustion analysis data for 11 were
unsuccesful as a result of an unidentified minor impurity that
cocrystallized with 11. For this reason, an isolated yield has also not
been reported.
[(PPP)Pt−Cl]2Pt(H)(Cl) (12). Compound 8 (67.7 mg, 0.0806
mmol) was loaded into a 20 mL vial and stirred in 10 mL of THF. The
resulting yellow mixture was allowed to stir vigorously for 12 h, and
the volatiles were subsequently removed to afford a yellow solid.
Crystallization of the crude product via vapor diffusion of diethyl ether
into a concentrated THF solution afforded analytically pure product as
(PPP)Pd−I (7). An identical procedure to that of compound 5 was
followed, using [PPP]-I (46.6 mg, 0.063 mmol) and Pd(PPh3)4 (73.1
1
mg, 0.063 mmol) to yield 7 (23.3 mg, 43.7%). H NMR (400 MHz,
1
CD2Cl2): δ 7.69 (m, 4H, Ar-H), 7.52 (m, 4H, Ar-H), 7.48−7.43 (m,
yellow crystals (23.2 mg, 45.2%). H NMR (400 MHz, CD2Cl2): δ
10H, Ar-H), 7.36 (m, 4H, Ar-H), 7.21 (m, 2H, Ar-H), 6.98 (m, 2H,
7.51 (m, 16H, Ar-H), 7.38−7.23 (m, 28H, Ar-H), 6.79 (m, 4H, Ar-H),
Ar-H), 6.86 (t, 2H, Ar-H), 3.83(m, 2H, CH2), 3.35 (m, 2H, CH2). 31
P
6.71 (m, 4H, Ar-H), 6.60 (m, 4H, Ar-H), 3.62 (m, 4H, CH2), 3.19 (m,
NMR (161.8 MHz, CD2Cl2): δ 242.2 (t, 1JP−P = 25.0 Hz), 5.7 (d, 1JP−P
= 25.0 Hz) 13C NMR (100.5 MHz, CDCl3): δ 136.1, 134.9, 134.4,
131.7, 130.4, 130.3, 128.5, 128.2, 121.9, 121.3, 52.0. Anal. Calcd for
C38H32N2IP3Pd: C, 54.15; H, 3.83; N, 3.32. Found: C, 54.26; H, 3.89;
N, 3.34.
4H, CH2), −17.1 (dt, 1H, Pt-H, 1JPt−H = 1300 Hz, 1JP−H = 21 Hz). 31
P
NMR (161.8 MHz, CD2Cl2): δ 152.9 (1JPt−P(side
= 529 Hz,
Pt)
1JPt−P(central Pt) = 2377 Hz, 2JP−P = 30 Hz), 4.1 (1JPt−P = 2586 Hz, 2JP−P
=
30 Hz). 13C NMR (100.5 MHz, CD2Cl2): δ 150.5, 135.8, 135.0, 134.1,
132.4, 130.5, 128.3, 128.2, 119.4, 118.5, 47.0. Anal. Calcd for
4177
dx.doi.org/10.1021/ic202581v | Inorg. Chem. 2012, 51, 4170−4179